Company · CIK 1689375
Entrada Therapeutics, Inc.
| CIK | 1689375 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | TRDA (Nasdaq) |
| First annual or quarterly report | 2021-12-09 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291306 | 2025-11-06 | 2025-12-03 | 2 | |
| 333-268099 | 2022-11-01 | 2024-06-24 | 4 | |
| 333-260160 | 2021-10-08 | 2021-11-01 | 4 |
Filings
11| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-12-03 | EFFECTDeclared effective | 333-291306 | 9999999995-25-003504 |
| 2025-11-06 | S-3Shelf registered | 333-291306 | 0001104659-25-107397 |
| 2024-06-24 | 424B5Shelf takedown | 333-268099 | 0001104659-24-074127 |
| 2023-09-29 | 424B5Shelf takedown | 333-268099 | 0001104659-23-105348 |
| 2022-11-07 | EFFECTDeclared effective | 333-268099 | 9999999995-22-003222 |
| 2022-11-01 | S-3Shelf registered | 333-268099 | 0001104659-22-113535 |
| 2021-11-01 | 424B4Final prospectus | 333-260160 | 0001104659-21-132334 |
| 2021-10-28 | EFFECTDeclared effective | 333-260160 | 9999999995-21-004082 |
| 2021-10-25 | S-1/AAmendment | 333-260160 | 0001104659-21-129181 |
| 2021-10-08 | S-1Registration filed | 333-260160 | 0001104659-21-124689 |
| 2021-08-06 | DRSDraft made public | 377-05320 | 0001104659-21-101417 |